首页> 外文期刊>ScientificWorldJournal >New Therapeutic Approaches for the Treatment of Rheumatoid Arthritis may Rise from the Cholinergic Anti-Inflammatory Pathway and Antinociceptive Pathway
【24h】

New Therapeutic Approaches for the Treatment of Rheumatoid Arthritis may Rise from the Cholinergic Anti-Inflammatory Pathway and Antinociceptive Pathway

机译:用于治疗类风湿性关节炎的新治疗方法可能从胆碱能抗炎途径和抗血巧途径上升

获取原文
           

摘要

Due to the complex etiology of rheumatoid arthritis (RA), it is difficult to be completely cured at the current stage although many approaches have been applied in clinics, especially the wide application of nonsteroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). New drug discovery and development via the recently discovered cholinergic anti-inflammatory and antinociceptive pathways should be promising. Based on the above, the nicotinic acetylcholine receptor agonists maintain the potential for the treatment of RA. Therefore, new therapeutic approaches may rise from these two newly discovered pathways. More preclinical experiments and clinical trials are required to confirm our viewpoint.
机译:由于类风湿性关节炎(RA)的复杂病因,虽然许多方法已应用于诊所,但尤其是广泛应用的非甾体类抗炎药(NSAIDs)和疾病改性抗逆肠溶液的难以完全固化药物(DMARDS)。通过最近发现的胆碱能抗炎和抗变性途径的新药物发现和发展应该是有前途的。基于上述,烟碱乙酰胆碱受体激动剂维持治疗RA的潜力。因此,新的治疗方法可能从这两个新发现的途径上升。需要更多的临床前实验和临床试验来确认我们的观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号